Baidu
map
ANIMALS-BASEL 润色咨询

Animals

出版年份：暂无数据 年文章数：9077 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：13.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2023-03-04 ms1000001523329524 来自安徽省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：动物实验
    经验分享：版面费1800瑞士法郎，折合人民币13000左右

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2022-08-14 zzzzfffvvv

    这个杂志好多专刊，

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2021-10-24 ms2000001374576478

    审稿速度:1.0
    经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2020-06-08 ms5534528927444041

    虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2020-03-03 ms391324488810565

    审稿速度:1.0
    经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2020-01-26 ms3352099995456729

    审稿速度:2.0
    经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。
    第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。
    12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2019-11-13 ms2466276523160074

    审稿速度:2.0
    经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2117457, encodeId=27fd211e457a6, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：动物实验<br>经验分享：版面费1800瑞士法郎，折合人民币13000左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47785565922, createdName=ms1000001523329524, createdTime=Sat Mar 04 11:23:36 CST 2023, time=2023-03-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238556, encodeId=7af6123855669, content=这个杂志好多专刊，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Sun Aug 14 06:43:03 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063364, encodeId=9bf91063364cb, content=审稿速度:1.0<br>经验分享：一审大修，一个接收，一个补试验，编辑给建议拒稿鼓励重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2db5646015, createdName=ms2000001374576478, createdTime=Sun Oct 24 09:26:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861576, encodeId=23808615e66c, content=虽然投稿被拒，但不得不出速度很快，一个星期内就收到结果 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Mon Jun 08 10:33:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858020, encodeId=dde7858020dd, content=审稿速度:1.0<br>经验分享：挺好的期刊，审稿过程把控也很严，三个审稿人，意见都很专业，当然也很难搞，应该是小同行，助理编辑处理很及时。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Tue Mar 03 23:20:41 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857080, encodeId=ef2985e08048, content=审稿速度:2.0<br>经验分享：挺不错的期刊，我是生物医药工程专业的，因为研究中涉及到了挺多动物的实验，于是就写了一篇投了过来。<br> 第一次投稿在9月底，大概十月中旬给了审稿意见，三位审稿人都很认真，肯定了工作的创新性，但也提了挺多意见，包括要补充数据，于是编辑给了拒稿鼓励重投。<br> 12月初重投，一月初给了大修的意见，两位专家一位接收，一位提了些问题，修改一周后重投，然后小修，校对，终于在1月25日也就是农历大年初一出版。整体还是比较不错的，认真回复审稿人的意见，应该机会挺大。另外编辑也很棒，效率很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c875414094, createdName=ms3352099995456729, createdTime=Sun Jan 26 17:12:57 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854941, encodeId=6c6f85494109, content=审稿速度:2.0<br>经验分享：animals 投了三个月，一个审稿人说直接接受，一个新审稿人说了一大堆空话，提一些问题语无伦次自己逻辑都不通，水准很低很低。不知道为啥别人这么快，我一个pending desicion 等了一个礼拜还没回复，如同在搞我 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Wed Nov 13 11:00:17 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845674, encodeId=2f618456e408, content=这个没被sci收录？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310c5414111, createdName=ms8261913720762277, createdTime=Fri Jul 27 19:09:06 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-27 ms8261913720762277

    这个没被sci收录？

    0

共8条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map